A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)
Learn more about:
Related Clinical Trial
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
Prevalence of Acute Hepatic Porphyria
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)
Acute Porphyria Biomarkers for Disease Activity
Panhematin for Prevention of Acute Attacks of Porphyria
Clinical Diagnosis of Acute Porphyria
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)